These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2611184

  • 1. Case of cerebrotendinous xanthomatosis. I: Unusual ophthalmic features.
    Morgan SJ, McKenna P, Bosanquet RC.
    Br J Ophthalmol; 1989 Dec; 73(12):1011-4. PubMed ID: 2611184
    [Abstract] [Full Text] [Related]

  • 2. Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid.
    Koopman BJ, Wolthers BG, van der Molen JC, Nagel GT, Kruizinga W.
    Biochim Biophys Acta; 1987 Feb 14; 917(2):238-46. PubMed ID: 3801500
    [Abstract] [Full Text] [Related]

  • 3. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Berginer VM, Salen G, Shefer S.
    N Engl J Med; 1984 Dec 27; 311(26):1649-52. PubMed ID: 6504105
    [Abstract] [Full Text] [Related]

  • 4. [Cerebrotendinous xanthomatosis: long-term treatment with chenodesoxycholic acid (author's transl)].
    Wolf LM, Houdent C, Laudat MH, Brasseur G, Balacheff O, Uzac L.
    Nouv Presse Med; 1982 Mar 06; 11(11):855-7. PubMed ID: 7070978
    [Abstract] [Full Text] [Related]

  • 5. Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis.
    Lewis B, Mitchell WD, Marenah CB, Cortese C, Reynolds EH, Shakir R.
    Br Med J (Clin Res Ed); 1983 Jul 02; 287(6384):21-2. PubMed ID: 6407679
    [No Abstract] [Full Text] [Related]

  • 6. [Timely treatment of cerebrotendinous xanthomatosis, a hereditary disorder of cholesterol metabolism].
    Waterreus RJ, de Jager AE, Koopman BJ, Wolthers BG, Suurmeyer AJ.
    Ned Tijdschr Geneeskd; 1984 Aug 25; 128(34):1604-7. PubMed ID: 6483031
    [No Abstract] [Full Text] [Related]

  • 7. Biochemical abnormalities in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Berginer V.
    Dev Neurosci; 1991 Aug 25; 13(4-5):363-70. PubMed ID: 1817043
    [Abstract] [Full Text] [Related]

  • 8. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
    Salen G, Berginer V, Shore V, Horak I, Horak E, Tint GS, Shefer S.
    N Engl J Med; 1987 May 14; 316(20):1233-8. PubMed ID: 3106810
    [Abstract] [Full Text] [Related]

  • 9. [A case of cerebrotendinous xanthomatosis with convulsive seizures].
    Matsumuro K, Takahashi K, Matsumoto H, Okatsu Y, Kuriyama M.
    Rinsho Shinkeigaku; 1990 Feb 14; 30(2):207-9. PubMed ID: 2190743
    [Abstract] [Full Text] [Related]

  • 10. Parkinsonism in cerebrotendinous xanthomatosis.
    Fujiyama J, Kuriyama M, Yoshidome H, Suehara M, Eiraku N, Kashio N, Osame M.
    Jpn J Med; 1991 Feb 14; 30(2):189-92. PubMed ID: 1865593
    [Abstract] [Full Text] [Related]

  • 11. Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis.
    Berginer VM, Shany S, Alkalay D, Berginer J, Dekel S, Salen G, Tint GS, Gazit D.
    Metabolism; 1993 Jan 14; 42(1):69-74. PubMed ID: 8446051
    [Abstract] [Full Text] [Related]

  • 12. Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing.
    Dotti MT, Salen G, Federico A.
    Dev Neurosci; 1991 Jan 14; 13(4-5):371-6. PubMed ID: 1817044
    [Abstract] [Full Text] [Related]

  • 13. EEG in cerebrotendinous xanthomatosis (CTX).
    Berginer VM, Radwan H, Korczyn AD, Kott E, Salen G, Shefer S.
    Clin Electroencephalogr; 1982 Apr 14; 13(2):89-96. PubMed ID: 7094358
    [No Abstract] [Full Text] [Related]

  • 14. Xanthomatosis as a cause of unilateral proptosis.
    Mohan H, Sen DK, Chatterjee PK.
    Indian J Ophthalmol; 1971 Jun 14; 19(2):77-9. PubMed ID: 15744974
    [No Abstract] [Full Text] [Related]

  • 15. [Cerebrotendinous xanthomatosis].
    Berginer VM.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992 Jun 14; 92(4):13-22. PubMed ID: 1333699
    [Abstract] [Full Text] [Related]

  • 16. [A case of cerebrotendinous xanthomatosis with spastic paraparesis, epilepsy, and bradykinesia].
    Kondo R, Wakamatsu N, Ishikawa A, Yuasa T, Miyatake T.
    Rinsho Shinkeigaku; 1991 Jun 14; 31(6):677-9. PubMed ID: 1934787
    [Abstract] [Full Text] [Related]

  • 17. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings.
    Chang WN, Kuriyama M, Chee EC.
    J Formos Med Assoc; 1994 Mar 14; 93(3):256-9. PubMed ID: 7920069
    [Abstract] [Full Text] [Related]

  • 18. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Pedley TA, Emerson RG, Warner CL, Rowland LP, Salen G.
    Ann Neurol; 1985 Oct 14; 18(4):517-8. PubMed ID: 4073846
    [Abstract] [Full Text] [Related]

  • 19. [Cerebrotendinous xanthomatosis with hyperthyroidism (author's transl)].
    Murakami S, Yamashita Y, Goto I, Kuroiwa Y, Ohnishi A.
    Rinsho Shinkeigaku; 1978 Jun 14; 18(6):312-20. PubMed ID: 699435
    [No Abstract] [Full Text] [Related]

  • 20. Joint hypermobility in patients with cerebrotendinous xanthomatosis.
    Sukenik S, Horowitz J, Berginer VM.
    J Rheumatol; 1989 Dec 14; 16(12):1611-2. PubMed ID: 2625697
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.